Cargando…

Cyclodextrin-based nanosponges as drug carriers

Cyclodextrin-based nanosponges, which are proposed as a new nanosized delivery system, are innovative cross-linked cyclodextrin polymers nanostructured within a three-dimensional network. This type of cyclodextrin polymer can form porous insoluble nanoparticles with a crystalline or amorphous struct...

Descripción completa

Detalles Bibliográficos
Autores principales: Trotta, Francesco, Zanetti, Marco, Cavalli, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Beilstein-Institut 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520565/
https://www.ncbi.nlm.nih.gov/pubmed/23243470
http://dx.doi.org/10.3762/bjoc.8.235
_version_ 1782252798611554304
author Trotta, Francesco
Zanetti, Marco
Cavalli, Roberta
author_facet Trotta, Francesco
Zanetti, Marco
Cavalli, Roberta
author_sort Trotta, Francesco
collection PubMed
description Cyclodextrin-based nanosponges, which are proposed as a new nanosized delivery system, are innovative cross-linked cyclodextrin polymers nanostructured within a three-dimensional network. This type of cyclodextrin polymer can form porous insoluble nanoparticles with a crystalline or amorphous structure and spherical shape or swelling properties. The polarity and dimension of the polymer mesh can be easily tuned by varying the type of cross-linker and degree of cross-linking. Nanosponge functionalisation for site-specific targeting can be achieved by conjugating various ligands on their surface. They are a safe and biodegradable material with negligible toxicity on cell cultures and are well-tolerated after injection in mice. Cyclodextrin-based nanosponges can form complexes with different types of lipophilic or hydrophilic molecules. The release of the entrapped molecules can be varied by modifying the structure to achieve prolonged release kinetics or a faster release. The nanosponges could be used to improve the aqueous solubility of poorly water-soluble molecules, protect degradable substances, obtain sustained delivery systems or design innovative drug carriers for nanomedicine.
format Online
Article
Text
id pubmed-3520565
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Beilstein-Institut
record_format MEDLINE/PubMed
spelling pubmed-35205652012-12-14 Cyclodextrin-based nanosponges as drug carriers Trotta, Francesco Zanetti, Marco Cavalli, Roberta Beilstein J Org Chem Review Cyclodextrin-based nanosponges, which are proposed as a new nanosized delivery system, are innovative cross-linked cyclodextrin polymers nanostructured within a three-dimensional network. This type of cyclodextrin polymer can form porous insoluble nanoparticles with a crystalline or amorphous structure and spherical shape or swelling properties. The polarity and dimension of the polymer mesh can be easily tuned by varying the type of cross-linker and degree of cross-linking. Nanosponge functionalisation for site-specific targeting can be achieved by conjugating various ligands on their surface. They are a safe and biodegradable material with negligible toxicity on cell cultures and are well-tolerated after injection in mice. Cyclodextrin-based nanosponges can form complexes with different types of lipophilic or hydrophilic molecules. The release of the entrapped molecules can be varied by modifying the structure to achieve prolonged release kinetics or a faster release. The nanosponges could be used to improve the aqueous solubility of poorly water-soluble molecules, protect degradable substances, obtain sustained delivery systems or design innovative drug carriers for nanomedicine. Beilstein-Institut 2012-11-29 /pmc/articles/PMC3520565/ /pubmed/23243470 http://dx.doi.org/10.3762/bjoc.8.235 Text en Copyright © 2012, Trotta et al. https://creativecommons.org/licenses/by/2.0https://www.beilstein-journals.org/bjoc/termsThis is an Open Access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: (https://www.beilstein-journals.org/bjoc/terms)
spellingShingle Review
Trotta, Francesco
Zanetti, Marco
Cavalli, Roberta
Cyclodextrin-based nanosponges as drug carriers
title Cyclodextrin-based nanosponges as drug carriers
title_full Cyclodextrin-based nanosponges as drug carriers
title_fullStr Cyclodextrin-based nanosponges as drug carriers
title_full_unstemmed Cyclodextrin-based nanosponges as drug carriers
title_short Cyclodextrin-based nanosponges as drug carriers
title_sort cyclodextrin-based nanosponges as drug carriers
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520565/
https://www.ncbi.nlm.nih.gov/pubmed/23243470
http://dx.doi.org/10.3762/bjoc.8.235
work_keys_str_mv AT trottafrancesco cyclodextrinbasednanospongesasdrugcarriers
AT zanettimarco cyclodextrinbasednanospongesasdrugcarriers
AT cavalliroberta cyclodextrinbasednanospongesasdrugcarriers